The Patent Finder

Richter Gedeon Nyrt.

44 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

17
Ending by 2030
Sep 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 25, 2026
    The maintenance fee for Indole Derivatives (US 10,329,296) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
  • 1 fee due Feb 18, 2027
    The maintenance fee for Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate (US 9,107,840) comes due Feb 18, 2027. Unpaid by Aug 18, 2027, it lapses early.
  • 1 fee due May 26, 2027
    The maintenance fee for Immunoglobulin Purification Using Pre-Cleaning Steps (US 10,487,138) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,221,788Pharmaceutical compositions containing rosuvastatin calcium
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,481,527Benzamide derivatives as bradykinin antagonists
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,875,610Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,943,621Salts of piperazine compounds as D3/D2 antagonists
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,450,476Process for the preparation of 17-hydroxy-6β,7β;15β,16β-bismethylene-17α-pregn-4-ene-3-one-21-carboxylic acid γ-lactone and key intermediates for this process
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,309,712Industrial process for the preparation of 17-hydroxy-6beta,7beta;15beta, 16beta-bismethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid y-lactone and key intermediates for this process
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,765,765Metabolites of (thio) carbamoyl-cyclohexane derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US RE47,350Pharmaceutical formulations containing dopamine receptor ligands
In force
 · From the USPTO record
In forceFrom the USPTO record
US RE49,302Pharmaceutical formulations containing dopamine receptor ligands
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,183,402Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 44 patents shown.
Pro members see all 44.
Pro members: see all 44 patents
Also on record, not counted in the 44: 29 lapsed for an unpaid fee · 1 ended at full term · 2 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 3 abandoned · 17 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited